Top segments and regional performance

Last year, the company generated ‪281.63 B‬ INR, the most of which — ‪281.63 B‬ INR — came from its top-performing segment, Pharmaceuticals and Related Products. The greatest contribution came from India, which accounted for ‪126.80 B‬ INR last year, with ‪116.15 B‬ INR the year before.